NCT05588726 (OUDInsomnia) is a NA clinical trial of Sleep Hygiene in Opioid Use Disorder, sponsored by University of Pennsylvania.

Who is sponsoring NCT05588726?

NCT05588726 is sponsored by University of Pennsylvania.

What drugs are being tested in NCT05588726?

Interventions in NCT05588726: Sleep Hygiene, Mindfulness.

What condition does NCT05588726 study?

NCT05588726 studies Opioid Use Disorder, Insomnia.

Is NCT05588726 still recruiting?

NCT05588726 is currently withdrawn. Last updated 25 May 2023.

Last reviewed 2023-05-25 · How we verify

NCT05588726: OUDInsomnia

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving Insomnia in Patients With Opioid Use Disorder

Withdrawn NA Last updated 25 May 2023

What this trial tests

NA trial testing Sleep Hygiene in Opioid Use Disorder. Withdrawn.

Timeline

1 January 2022

Primary endpoint
23 May 2023

23 May 2023

Quick facts

Lead sponsor	University of Pennsylvania
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Start date	1 January 2022
Primary completion	23 May 2023
Estimated completion	23 May 2023
Sites	1 location across United States

Drugs / interventions tested

Sleep Hygiene
Mindfulness

Conditions studied

Opioid Use Disorder — all drugs for Opioid Use Disorder →
Insomnia — all drugs for Insomnia →

Sponsor

University of Pennsylvania

Who can join

18 and older, any sex, with Opioid Use Disorder or Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized, 35-day research study (n=20) explores the effects of a simplified mindfulness intervention in opioid use disorder patients stabilized on buprenorphine maintenance therapy (BMT), aiming to alleviate insomnia, monitor BMT dose, and decrease non-prescribed opioid use. Patients tap along with their breathing at bedtime and practice sleep hygiene; controls do sleep hygiene only. Adherence will be monitored by a smartphone application.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sleep Hygiene

Trials testing the same drug.

NCT06497894 — No More Sleepless Nights in Perimenopause · Phase 4 · recruiting
NCT07069517 — Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD · NA · recruiting
NCT06335784 — Mental Imagery and Targeted Memory Reactivation in Insomnia · NA · recruiting
NCT05530863 — Behavioral Relaxation Approaches for Insomnia in Pregnant Patients · NA · enrolling by invitation
NCT04316663 — Well-being Promotion and Sleep Hygiene Education to Improve Sleep Quality · NA · completed

Other recruiting trials for Opioid Use Disorder

Currently open trials in the same condition.

NCT07278518 — Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine · NA · recruiting
NCT07044466 — Social Functioning in Opioid Use Disorder · NA · recruiting
NCT07158853 — Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder · NA · recruiting
NCT06943859 — Ketamine for Opioid Use Disorder · Phase 2 · recruiting
NCT06651177 — Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder · Phase 2 · recruiting

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05588726 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 25 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05588726.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing